An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Depressive Disorder, Major
Interventions
DRUG

Radafaxine

Trial Locations (21)

20037

GSK Investigational Site, Washington D.C.

20852

GSK Investigational Site, Rockville

27103

GSK Investigational Site, Winston-Salem

30060

GSK Investigational Site, Marietta

32216

GSK Investigational Site, Jacksonville

33437

GSK Investigational Site, Boynton Beach

33613

GSK Investigational Site, Tampa

37203

GSK Investigational Site, Nashville

38119

GSK Investigational Site, Memphis

43623

GSK Investigational Site, Toledo

46202

GSK Investigational Site, Indianapolis

47905

GSK Investigational Site, Lafayette

60048

GSK Investigational Site, Libertyville

60181

GSK Investigational Site, Oakbrook Terrace

63301

GSK Investigational Site, Saint Charles

71101

GSK Investigational Site, Shreveport

87108

GSK Investigational Site, Albuquerque

90703

GSK Investigational Site, Cerritos

92108

GSK Investigational Site, San Diego

98004

GSK Investigational Site, Bellevue

78229-3815

GSK Investigational Site, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY